To determine if MDSCs inhibit the activity of T cells, we purified MDSCs from tumor tissues of cancer patients and from their PBMCs, and then we co-cultured them separately with autologous T cells at the 1:2 ratios in the presence of CD3/CD28 antibody stimulation for 72 hours. Here, CD28 is linked to cancer.